Press Releases Year None202220212020201920182017201620152014 Jul 06, 2022 Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity Keep Reading Jun 30, 2022 Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology Keep Reading Jun 16, 2022 Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit Keep Reading Jun 07, 2022 Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening Keep Reading Jun 02, 2022 Twist Bioscience to Present at Upcoming Investor Conferences Keep Reading May 31, 2022 Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications Keep Reading May 18, 2022 Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference Keep Reading May 10, 2022 Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit Keep Reading May 09, 2022 Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression Keep Reading May 05, 2022 Twist Bioscience Reports Second Quarter 2022 Financial Results Keep Reading First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Next page next › Last page last » Print Page Email Page Email Alerts RSS Feeds
Year None202220212020201920182017201620152014 Jul 06, 2022 Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity Keep Reading Jun 30, 2022 Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology Keep Reading Jun 16, 2022 Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit Keep Reading Jun 07, 2022 Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening Keep Reading Jun 02, 2022 Twist Bioscience to Present at Upcoming Investor Conferences Keep Reading May 31, 2022 Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications Keep Reading May 18, 2022 Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference Keep Reading May 10, 2022 Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit Keep Reading May 09, 2022 Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression Keep Reading May 05, 2022 Twist Bioscience Reports Second Quarter 2022 Financial Results Keep Reading First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Next page next › Last page last »
Jul 06, 2022 Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity Keep Reading
Jun 30, 2022 Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology Keep Reading
Jun 16, 2022 Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit Keep Reading
Jun 07, 2022 Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening Keep Reading
May 31, 2022 Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications Keep Reading
May 10, 2022 Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit Keep Reading
May 09, 2022 Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression Keep Reading
